PURE Bioscience Q2 Financial Results Analysis
Monday, 18 March 2024, 20:52
PURE Bioscience Q2 Financial Results:
PURE Bioscience reports its financial performance for the second quarter with a net loss per share of -$0.01 indicating a decline. The revenue stands at $0.33 million, reflecting a 17.5% YoY decrease.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.